WWWei Wang

Wei Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wei Wang has a total of 272 co-authors. Here are the top co-authors by number of shared publications:

  • Lu Tang

    31 shared publications
  • Yue Yin

    State Key Laboratory of Natural Medicines Department of Pharmaceutics School of Pharmacy China Pharmaceutical University Nanjing P. R. China

    26 shared publications
  • Hening Liu

    State Key Laboratory of Natural Medicines Department of Pharmaceutics School of Pharmacy China Pharmaceutical University Nanjing P. R. China

    24 shared publications
  • Cong Fu

    State Key Laboratory of Natural Medicines Department of Pharmaceutics School of Pharmacy China Pharmaceutical University Nanjing P. R. China

    23 shared publications
  • Min Li

    State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China

    16 shared publications
  • Qiaqia Xiao

    16 shared publications

Latest Publications

  • Intranasal Pathogenesis‐Adaptive Nanotherapeutics Reinstate Regenerative Competence for Post‐Stroke Neural Repair

    by Yue Yin, Zihan Wang, Mingyang Xue, Qiaoqiao Zhao, Zixuan Li, Weijie Shu, Zixuan Wang, Hening Liu, Bei Lv, Hao Qin, et al.

    Poststroke neurorehabilitation is limited by the poor regenerative capacity of adult neurons. Although neural stem cells (NSCs) can generate new neurons, their reparative potential is constrained by inefficient delivery to cerebral lesions and a hostile regenerative niche. Here, analysis of a single‐nucleus transcriptomic dataset revealed pronounced dysfunction and intercellular crosstalk among neurons, microglia, and NSCs, highlighting redox imbalance and impaired nitric oxide (NO) signaling as potential therapeutic targets. Guided by these findings, we develop FCeO 2 @GLp, a pathogenesis‐adaptive nanotherapeutic integrating reactive oxygen species scavenging, NO replenishment and immune modulation within cerebral ischemic microenvironment. Following intranasal administration, FCeO 2 @GLp actively adheres to the olfactory epithelium (OE), reaches infarcted brain regions, releases cerium oxide (CeO 2 ) nanozyme, fingolimod, and a NO donor in response to local acidity. This coordinated strategy alleviates oxidative stress, reprograms microglia, protects neurons, and enhances NSC proliferation and neuronal differentiation. Consequently, FCeO 2 @GLp effectively reduces infarct volume and cerebral edema during the acute phase, and improves long‐term neurological function and survival, establishing a lesion‐responsive strategy for poststroke neural repair.

  • A Self‐Reinforcing Hydrogel Orchestrates Dynamic Microenvironment Reprogramming for High‐Quality Diabetic Skin Regeneration

    by Yi Zhang, Hening Liu, Yuanbo Zhu, Yue Yin, Zixuan Wang, Weijie Shu, Yubing Lu, Ye Ding, Zihan Wang, Cong Fu, et al.

    Chronic diabetic wounds are characterized by persistent inflammation, bacterial infection, oxidative stress, hypoxia, impaired angiogenesis, and pathological fibrosis. Herein, a self‐reinforcing hydrogel dressing (RNPP) is developed by integrating copper peroxide (CuO 2 )/manganese dioxide (MnO 2 ) hybrid nanozymes and ginsenoside Rg1 (Rg1) into a sodium polyacrylate/polymetformin matrix for wound microenvironment regulation and high‐quality diabetic wound healing. RNPP rapidly promotes hemostasis, absorbs exudate, and maintains a moist protective interface. CuO 2 /MnO 2 nanozymes provide non‐antibiotic antibacterial activity through Cu 2+ release while scavenging excessive reactive oxygen species and converting endogenous H 2 O 2 into oxygen, thereby alleviating oxidative stress and hypoxia, promoting pro‐regenerative macrophage polarization, angiogenesis, and re‐epithelialization. Meanwhile, released Cu 2+ dynamically coordinates with polymetformin, reducing free Cu 2+ toxicity while reinforcing the hydrogel network. Sustained Rg1 release further modulates the transforming growth factor‐β1 (TGF‐β1)/α‐smooth muscle actin (α‐SMA) axis and suppresses myofibroblast overactivation, thereby attenuating fibrotic signaling and promoting organized collagen remodeling. These effects suggest a favorable microenvironment for improved tissue remodeling. Consequently, RNPP accelerates tissue repair in diabetic and MRSA‐infected wounds while favoring regenerative tissue remodeling, providing a multifunctional material strategy for chronic wound management.

  • Organic nanocarrier-integrated polymeric microneedle patches for localized management of multiple diseases

    by Yue Yin, Wei Wang, Zixuan Li, Xuejing Li, Zihan Wang, Qiaoqiao Zhao, Hening Liu, Yi Zhang, Bei Lv, Zixuan Wang, et al.


  • A violet phosphorus-engineered immunogel for combating TNBC progression via tumor microenvironment remodeling

    by Yijun Mei, Jingyi Hu, Yuanyuan Cao, Xueyu Gao, Wanting Liao, Cong Fu, Zhencheng Gao, Lu Tang, Jinying Zhang, Wei Wang


  • Open Access

    Immune‐Engineered Hydrogels Combat Orthotopic and Metastatic Cancer via Hypoxia‐Relieved Photodynamic Therapy and Ferroptotic Cell Death

    by Cong Fu, Yuanyuan Cao, Yijun Mei, Qiaqia Xiao, Jingyi Hu, Zhencheng Gao, Xueyu Gao, Yi Hou, Fei Zhang, Guangda Zhu, et al.

    Hypoxia severely impairs photodynamic therapy (PDT) by limiting oxygen availability and activating HIF‐1α‐mediated immunosuppressive pathways. Herein, we develop fully functional immune hydrogels (AV@PFgel) that synergistically integrate hypoxia relief, ferroptosis induction, and violet phosphorus nanosheet (VPN)‐induced PDT within a single therapeutic platform to potentiate antitumor immunity. The dual‐crosslinked AV@PFgel degrades in acidic tumor microenvironment (TME) to enable oxygen generation and Fenton reaction‐mediated ferroptosis through released PolyMet, Fe 3+ , and acriflavine (ACF)‐loaded VPN, jointly promoting immunogenic cell death (ICD). VPN, acting as a potent photosensitizer, triggers PDT for direct tumor ablation and ICD induction, whereas ACF‐mediated HIF‐1α inhibition counteracts hypoxia‐associated immunosuppression. Notably, AV@PFgel reprograms the TME into an immunostimulatory state, eliciting durable local and systemic antitumor immune responses. Consequently, a single intratumoral administration of AV@PFgel combined with regular laser irradiation markedly suppresses primary and metastatic triple‐negative breast cancer, highlighting its translational promise for long‐term cancer immunotherapy. Collectively, this work presents a versatile and integrated strategy to overcome the hypoxia barrier while coordinately activating both innate and adaptive immune responses, paving the way for advanced cancer immunotherapy with improved and durable efficacy.


  • Natural Compound-Driven Nano-Self-Assembly for Multimechanistic Transdermal Antiobesity Therapy

    by Lu Tang, Qiaqia Xiao, Siying Chen, Chuying Wang, Mickel Mikhael, Zheming Niu, Linghui Wang, Cong Fu, Yi Hou, Guangda Zhu, et al.

    Obesity is a complex metabolic disorder characterized by excessive fat accumulation and chronic, low-grade inflammation, contributing to a range of associated diseases. Conventional treatments are often limited by poor targeting, low efficacy, and undesirable side effects. Natural compounds with anti-inflammatory and metabolic regulatory properties have attracted considerable attention due to their safety and multitarget mechanisms. Herein, we propose an effective antiobesity strategy involving the construction of a carrier-free nanodrug (CG NPs) via the self-assembly of two natural compounds, curcumin (Cur) and glycyrrhetinic acid (GA), both of which exhibit multiple antiobesity effects. To achieve efficient and targeted delivery, CG NPs are incorporated into a dissolvable microneedle coated with black phosphorus nanosheets (CG@BP/MN), forming a biocompatible transdermal platform. When combined with mild photothermal therapy, CG@BP/MN enables transdermal drug delivery to modulate subcutaneous fat, efficiently promoting white adipose tissue browning, enhancing lipolysis, and modulating macrophage polarization. Cur and GA act synergistically to regulate lipid metabolism, attenuate inflammation, and improve insulin sensitivity. In a diet-induced obesity mouse model, this therapeutic plan significantly reduces body weight, elevates energy expenditure, and prevents weight regain following treatment cessation. Overall, this therapeutic platform represents a safe, effective, and clinically promising approach to the long-term management of obesity.


  • Open Access

    From conceptual design to translational progress: Emerging advances in intelligent microneedles for biomedical applications

    by Yue Yin, Qiaoqiao Zhao, Zihan Wang, Zixuan Li, Hening Liu, Fatemeh Eghbalitabar, Jing Shang, Lu Tang, Wei Wang


  • Top Cited Papers
    Open Access

    Intranasal blood-brain barrier bypass enables sequential mitochondria-targeted bioengineered nanolamellar system for ischemic stroke therapy

    by Yue Yin, Zixuan Li, Weijie Shu, Hening Liu, Zihan Wang, Cong Fu, Yuanbo Zhu, Xuejing Li, Yi Zhang, Bei Lv, et al.

    Mitochondrial damage constitutes the central pathological mechanism of cerebral ischemia-reperfusion (I/R) injury. Targeted delivery of antioxidants to mitochondria and the phenotype polarization of glial cells holds great promise for effective treatment. However, the blood-brain barrier (BBB) remains a major obstacle, causing insufficient drug accumulation in neuronal mitochondria. Here, we develop a bioengineered nanolamellar system (MM@BPPF) by coating microglia-mitochondria hybrid biomembrane onto black phosphorus nanosheets (BP NSs) loaded with polymetformin (PolyMet) and fingolimod hydrochloride (FTY720). Microglia membrane facilitates inflammation-directed targeting to the injured brain regions, while mitochondria membrane confers homotypic targeting to mitochondria. Meanwhile, BP NSs, PolyMet, and FTY720 act sequentially to restore mitochondrial function of neuronal cells and modulate microglial polarization. Intranasal administration enables MM@BPPF to bypass the BBB, substantially improving brain-targeting efficiency. This work not only offers an innovative sequential targeting strategy for mitigating I/R injury but also presents a potential paradigm for treating other central nervous system disorders.


  • Top Cited Papers
    Open Access

    Advances in Nanotechnology-Based Topical Delivery Systems for Skincare Applications

    by Ziwei Yan, Sunxin Zhang, Guyuan Wu, Yunxiang Kang, Cong Fu, Zihan Wang, Guoqi Wang, Lu Tang, Wei Wang

    The growing demand for effective skincare products that can effectively target specific dermatological concerns has accelerated the development of advanced delivery technologies. Among them, nanocarrier-based topical delivery systems have gained significant attention for their ability to enhance the performance of skincare formulations. Acting as versatile delivery tools, nanocarriers not only stabilize and protect sensitive cosmetic ingredients but also improve their penetration through the skin barrier and enable controlled, sustained, or targeted release. Therefore, this review focuses on the recent achievements of nanocarrier-based topical delivery technology for skincare applications, which systematically summarizes the design principles, mechanisms and functional characteristics of diverse nano-based delivery platforms, including vesicular nanocarriers, lipid-based nanocarriers, emulsion-based nanocarriers, polymeric nanocarriers, inorganic nanoparticles, and inclusion complexes. Meanwhile, these nanocarriers are discussed according to their relevance to the pathogenesis of prevalent skin disorders, highlighting how tailored nanocarriers can address specific therapeutic or cosmetic needs. Overall, this review emphasizes the emerging trends and future perspectives of nanotechnology-based topical delivery systems in modern cosmetology, offering more opportunities for precise, effective and science-driven cosmetic solutions.


  • Site‐Specific Antibacterial Strategy for Multi‐Pathway Treatment of Drug‐Resistant Skin Infections

    by Lu Tang, Hening Liu, Jingwen Feng, Yi Yao, Yuqi Cao, Yue Yin, Cong Fu, Jifan Gao, Qiaqia Xiao, Ziwei Yan, et al.

    Drug‐resistant skin infections, especially those caused by multidrug‐resistant (MDR) bacteria, remain a major public health concern due to the limited efficacy of conventional antibiotics and biofilm‐associated tolerance. Herein, a site‐specific antibacterial strategy based on a multi‐pathway microneedle (MN) patch system is presented for effective treatment of methicillin‐resistant Staphylococcus aureus (MRSA)‐infected wounds and abscesses. The MN patch co‐delivers vancomycin and photoactive black phosphorus quantum dots (BPQDs) encapsulated in macrophage membrane‐coated cationic liposomes, thereby integrating antibiotic therapy with phototherapy. Upon light activation, BPQDs generate localized hyperthermia and reactive oxygen species, which synergize with vancomycin to eradicate bacteria and reduce the risk of resistance development. The dissolvable MN array ensures efficient penetration through the skin barrier, enabling targeted and sustained release at the infection site. In vivo, this multi‐pathway intervention significantly accelerates wound closure, reduces abscess size, suppresses inflammation, and promotes tissue regeneration by remodeling the infectious microenvironment. Overall, this work demonstrates a promising localized therapeutic platform that harnesses multi‐pathway antibacterial mechanisms to combat MDR bacteria and facilitate the healing of drug‐resistant skin infections.